Drug and Alcohol Treatment Discharges and Length of Stay

Treatment Episode Data Set (TEDS):  2005 Discharges from Substance Abuse Treatment Services (HTML)   (PDF format) Providing data on treatment completion rates by type of substance abuse care (inpatient, outpatient, hospital, methadone maintenance, etc.)

All treatment reports

Length of stay for treatment

Treatment completion/success

Length of Stay in Treatment

Also see Treatment Completion/Success

• The DASIS Report:  Length of Stay for Outpatient Discharges Completing Treatment: 2004

• Trends in treatment completion rates by demographics (2002-2004)  table

• Treatment Episode Data Set (TEDS):  2004 Discharges  (HTML)
  • Median Length of Stay (highlights)

• Client Characteristics Associated with Treatment Completion or Transfer to Further Treatment

• Table 2.5 -- Year 2004 discharges, by type of service and reason for discharge: TEDS 2004 (Number, percent distribution, and median and average lengths of stay)

• Table 2.6 -- Year 2004 discharges from methadone treatment, by type of service, according to reason for discharge: TEDS 2004(Number, percent distribution, and median and average lengths of stay)

• Figure 2.3 - - Median length of stay, by reason for discharge and type of service: TEDS 2004

• Figure 2.4- - Average length of stay, by reason for discharge and type of service: TEDS 2004

• Length of Stay among Female Clients in Substance Abuse Treatment Chapter 6 in Health Services Utilization by Individuals with Substance Abuse and Mental Disorders, 2002 (HTML format) 

• 2001 TEDS Report:  Length of Stay in Treatment

• The DASIS Report:  Admissions with Five or More Prior Treatment Episodes: 2002

• The DASIS Report:  Discharges from Detoxification, 2000

• The DASIS Report:  Discharges from Long-term Residential Treatment, 2000

• The DASIS Report:  Discharges from Short-term Residential Treatment, 2000

• The DASIS Report:  Discharges from Intensive Outpatient Treatment, 2000

• The DASIS Report:  Discharges from Outpatient Treatment, 2000

• 2000 TEDS Report:  Length of Stay in Treatment

• Services Research Outcomes Study (SROS) full report

• Length of Stay
• Figure 3-7:  Percentage change in drug use by length of stay
• Length of stay and change in drug use after treatment
• Changes in criminal behavior by length of stay
• Figure 3-12: Changes in criminal behavior by length of stay

Treatment Completion/Success/Discharge

The TEDS Report - - Treatment Outcomes among Clients Discharged from Outpatient Substance Abuse Treatment

The TEDS Report:  Treatment Outcomes among Clients Discharged from Residential Substance Abuse Treatment: 2005

Treatment Episode Data Set (TEDS):  2005 Discharges from Substance Abuse Treatment Services (HTML)   (PDF format) Providing data on treatment completion rates by type of substance abuse care (inpatient, outpatient, hospital, methadone maintenance, etc.)

The DASIS Report:  Length of Stay for Outpatient Discharges Completing Treatment: 2004

Trends in treatment completion rates by demographics (2002-2004): table

Treatment Episode Data Set (TEDS):  2004 Discharges  (HTML)

• Treatment Completion (highlights)

• Client Characteristics Associated with Treatment Completion or Transfer to Further Treatment

• Table 2.4 -- Year 2004 discharges, by State and reason for discharge: TEDS 2004 (Number and percent distribution)

• Table 2.5 -- Year 2004 discharges, by type of service and reason for discharge: TEDS 2004 (Number, percent distribution, and median and average lengths of stay)

• Table 2.6 -- Year 2004 discharges from methadone treatment, by type of service, according to reason for discharge: TEDS 2004(Number, percent distribution, and median and average lengths of stay

• Figure 2.2 - - Reason for discharge, by type of service: TEDS 2004

The DASIS Report: Discharges Who Left Against Professional Advice, 2003

Reason for Discharge:  2001 TEDS Report

Treatment Completion:  2001 TEDS Report

The DASIS Report:  Admissions with Five or More Prior Treatment Episodes: 2002

The DASIS Report:  Discharges from Detoxification, 2000

The DASIS Report:  Discharges from Hospital Inpatient Treatment, 2000

The DASIS Report:  Discharges from Long-term Residential Treatment, 2000

The DASIS Report:  Discharges from Short-term Residential Treatment, 2000

Number of Prior Treatments:  2000 TEDS Report

Reason for Discharge:  2000 TEDS Report

Treatment Completion:  2000 TEDS Report

The DASIS Report:  Discharges from Intensive Outpatient Treatment, 2000

The DASIS Report:  Discharges from Outpatient Treatment, 2000

The NSDUH Report:  Reasons for Not Receiving Substance Abuse Treatment

The NSDUH Report:  Reasons for Not Receiving Treatment Among Adults with Serious Mental Illness

The DASIS Report: Treatment Completion in the Treatment Episode Data Set (TEDS)

Treatment Gap:  National and State Estimates of the Drug Abuse Treatment Gap (HTML)

Services Research Outcomes Study (SROS) full report

• Alcohol & drug use 5 years before and after treatment
• Correlates of treatment outcomes
• Heroin use by treatment completion status
• Driving under the influence by treatment completion status
• Length of Stay
• Figure 3-7:  Percentage change in drug use by length of stay
• Length of stay and change in drug use after treatment
• Changes in criminal behavior by length of stay
• Table B-40:  mean number of additional treatments after SROS admission
• Figure 3-12: Changes in criminal behavior by length of stay

This page was last updated on April 23, 2009.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

   Site Map | Contact Us | Accessibility | Privacy Policy | Freedom of Information Act
 Disclaimer | Department of Health and Human Services | SAMHSA | White House | USA.gov

* PDF formatted files require that Adobe Acrobat Reader® program is installed on your computer. Click here to download this FREE software now from Adobe.

What's New

Highlights

Topics

Data

Drugs

Pubs

Short Reports

Treatment

Help

Mail

OAS